These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

863 related articles for article (PubMed ID: 15634032)

  • 1. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
    Czock D; Keller F; Rasche FM; Häussler U
    Clin Pharmacokinet; 2005; 44(1):61-98. PubMed ID: 15634032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of gender effect on the pharmacokinetics and pharmacodynamics of dexamethasone in the camel after intravenous administration.
    Al Katheeri NA; Wasfi IA; Lambert M; Saeed A
    Res Vet Sci; 2004 Aug; 77(1):73-81. PubMed ID: 15120956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone.
    Möllmann H; Hochhaus G; Rohatagi S; Barth J; Derendorf H
    Pharm Res; 1995 Jul; 12(7):1096-100. PubMed ID: 7494809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring glucocorticoid therapy: a pharmacokinetic approach.
    Hill MR; Szefler SJ; Ball BD; Bartoszek M; Brenner AM
    Clin Pharmacol Ther; 1990 Oct; 48(4):390-8. PubMed ID: 2225699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortisol pharmacodynamics after methylprednisolone administration in young and elderly males.
    Tornatore KM; Logue G; Venuto RC; Davis PJ
    J Clin Pharmacol; 1997 Apr; 37(4):304-11. PubMed ID: 9115056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of inhaled glucocorticoids.
    Padden J; Skoner D; Hochhaus G
    J Asthma; 2008; 45 Suppl 1():13-24. PubMed ID: 19093281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids.
    Meduri GU; Tolley EA; Chrousos GP; Stentz F
    Am J Respir Crit Care Med; 2002 Apr; 165(7):983-91. PubMed ID: 11934726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective.
    Rohatagi S; Appajosyula S; Derendorf H; Szefler S; Nave R; Zech K; Banerji D
    J Clin Pharmacol; 2004 Jan; 44(1):37-47. PubMed ID: 14681340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of glucocorticoids.
    Strehl C; Spies CM; Buttgereit F
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S13-8. PubMed ID: 22018178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy.
    Buttgereit F; Brand MD; Burmester GR
    Biochem Pharmacol; 1999 Jul; 58(2):363-8. PubMed ID: 10423179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of methylprednisolone after one bolus dose compared with two dose fractions.
    Uhl A; Czock D; Boehm BO; Zellner D; Mertz A; Keller F
    J Clin Pharm Ther; 2002 Aug; 27(4):281-7. PubMed ID: 12174030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic/pharmacodynamic modelling of effects of dexamethasone and prednisolone in combination with endogenous cortisol on lymphocyte counts and systemic markers of bone turn over and inflammation in healthy and asthmatic men.
    Dubois EF; Derks MG; Schweitzer DH; Zwinderman AH; Dekhuijzen PN; van Boxtel CJ
    Eur J Clin Pharmacol; 2004 Jul; 60(5):315-28. PubMed ID: 15150679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacology of glucocorticoids and ENT pathology].
    Devillier P
    Presse Med; 2001 Dec 22-29; 30(39-40 Pt 2):59-69. PubMed ID: 11819915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic and nongenomic effects of glucocorticoids.
    Stahn C; Buttgereit F
    Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulse glucocorticoid therapy. The 'big shot' revisited.
    Roujeau JC
    Arch Dermatol; 1996 Dec; 132(12):1499-502. PubMed ID: 8961881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids in the Treatment of Glomerular Diseases: Pitfalls and Pearls.
    Ponticelli C; Locatelli F
    Clin J Am Soc Nephrol; 2018 May; 13(5):815-822. PubMed ID: 29475991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and clinical relevance of nongenomic glucocorticoid actions.
    Buttgereit F
    Z Rheumatol; 2000; 59 Suppl 2():II/119-23. PubMed ID: 11155791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid non-genomic inhibitory effects of glucocorticoids on human neutrophil degranulation.
    Liu L; Wang YX; Zhou J; Long F; Sun HW; Liu Y; Chen YZ; Jiang CL
    Inflamm Res; 2005 Jan; 54(1):37-41. PubMed ID: 15723203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
    Sotelo J; Jung H
    Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of drug-drug interactions between voriconazole and glucocorticoids.
    Li M; Zhu L; Chen L; Li N; Qi F
    J Chemother; 2018 Sep; 30(5):296-303. PubMed ID: 30843777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.